nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—Fentanyl—Benzphetamine—obesity	0.255	1	CrCrCtD
Alfentanil—ORM1—Bupropion—obesity	0.139	0.353	CbGbCtD
Alfentanil—ALB—obesity	0.135	1	CbGaD
Alfentanil—CYP3A7—Cimetidine—obesity	0.0459	0.117	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Cimetidine—obesity	0.0459	0.117	CbGbCtD
Alfentanil—CYP3A5—Cimetidine—obesity	0.0344	0.0877	CbGbCtD
Alfentanil—CYP3A4—Sibutramine—obesity	0.0284	0.0723	CbGbCtD
Alfentanil—ABCB1—Cimetidine—obesity	0.0224	0.0571	CbGbCtD
Alfentanil—CYP3A4—Benzphetamine—obesity	0.0215	0.0548	CbGbCtD
Alfentanil—CYP3A4—Bupropion—obesity	0.0183	0.0466	CbGbCtD
Alfentanil—CYP3A4—Orlistat—obesity	0.0149	0.038	CbGbCtD
Alfentanil—CYP3A4—Cimetidine—obesity	0.0134	0.0342	CbGbCtD
Alfentanil—CYP3A4—Topiramate—obesity	0.00879	0.0224	CbGbCtD
Alfentanil—ORM1—bile—obesity	0.00425	0.309	CbGeAlD
Alfentanil—Disorientation—Cimetidine—obesity	0.00121	0.00943	CcSEcCtD
Alfentanil—ORM1—gall bladder—obesity	0.00118	0.0859	CbGeAlD
Alfentanil—Myoclonus—Bupropion—obesity	0.00116	0.009	CcSEcCtD
Alfentanil—Drowsiness—Phenylpropanolamine—obesity	0.00105	0.00821	CcSEcCtD
Alfentanil—ALB—gall bladder—obesity	0.00103	0.0753	CbGeAlD
Alfentanil—Agitation—Methamphetamine—obesity	0.00101	0.00785	CcSEcCtD
Alfentanil—Agitation—Benzphetamine—obesity	0.000972	0.00757	CcSEcCtD
Alfentanil—Apnoea—Sibutramine—obesity	0.000941	0.00733	CcSEcCtD
Alfentanil—Dermatitis atopic—Bupropion—obesity	0.000939	0.00731	CcSEcCtD
Alfentanil—Vision blurred—Phendimetrazine—obesity	0.000909	0.00708	CcSEcCtD
Alfentanil—Agitation—Phendimetrazine—obesity	0.000886	0.0069	CcSEcCtD
Alfentanil—Drowsiness—Diethylpropion—obesity	0.000878	0.00683	CcSEcCtD
Alfentanil—Tachycardia—Methamphetamine—obesity	0.000874	0.00681	CcSEcCtD
Alfentanil—Arrhythmia—Phenylpropanolamine—obesity	0.000845	0.00658	CcSEcCtD
Alfentanil—Tachycardia—Benzphetamine—obesity	0.000843	0.00656	CcSEcCtD
Alfentanil—Drowsiness—Cimetidine—obesity	0.000835	0.0065	CcSEcCtD
Alfentanil—Hyperhidrosis—Benzphetamine—obesity	0.000835	0.0065	CcSEcCtD
Alfentanil—Blood pressure increased—Sibutramine—obesity	0.000798	0.00621	CcSEcCtD
Alfentanil—Vision blurred—Phenylpropanolamine—obesity	0.000776	0.00605	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methamphetamine—obesity	0.000773	0.00602	CcSEcCtD
Alfentanil—Tachycardia—Phendimetrazine—obesity	0.000768	0.00598	CcSEcCtD
Alfentanil—Bradycardia—Cimetidine—obesity	0.000763	0.00594	CcSEcCtD
Alfentanil—Hyperhidrosis—Phendimetrazine—obesity	0.000761	0.00592	CcSEcCtD
Alfentanil—Agitation—Phenylpropanolamine—obesity	0.000757	0.00589	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Benzphetamine—obesity	0.000745	0.00581	CcSEcCtD
Alfentanil—Dyskinesia—Bupropion—obesity	0.00074	0.00576	CcSEcCtD
Alfentanil—Agitation—Phentermine—obesity	0.000724	0.00564	CcSEcCtD
Alfentanil—Urticaria—Methamphetamine—obesity	0.000711	0.00554	CcSEcCtD
Alfentanil—Arrhythmia—Diethylpropion—obesity	0.000704	0.00548	CcSEcCtD
Alfentanil—Blood pressure increased—Bupropion—obesity	0.000695	0.00541	CcSEcCtD
Alfentanil—Urticaria—Benzphetamine—obesity	0.000686	0.00534	CcSEcCtD
Alfentanil—Erythema—Diethylpropion—obesity	0.000686	0.00534	CcSEcCtD
Alfentanil—Euphoric mood—Sibutramine—obesity	0.000685	0.00534	CcSEcCtD
Alfentanil—Hypertension—Phentermine—obesity	0.000681	0.0053	CcSEcCtD
Alfentanil—Confusional state—Phenylpropanolamine—obesity	0.000678	0.00528	CcSEcCtD
Alfentanil—Hypersensitivity—Methamphetamine—obesity	0.00066	0.00514	CcSEcCtD
Alfentanil—Tachycardia—Phenylpropanolamine—obesity	0.000656	0.00511	CcSEcCtD
Alfentanil—Vision blurred—Diethylpropion—obesity	0.000646	0.00503	CcSEcCtD
Alfentanil—Hypersensitivity—Benzphetamine—obesity	0.000636	0.00495	CcSEcCtD
Alfentanil—Agitation—Diethylpropion—obesity	0.00063	0.00491	CcSEcCtD
Alfentanil—Hypotension—Phenylpropanolamine—obesity	0.000628	0.00489	CcSEcCtD
Alfentanil—Tachycardia—Phentermine—obesity	0.000628	0.00489	CcSEcCtD
Alfentanil—CYP3A7—endocrine gland—obesity	0.000606	0.0441	CbGeAlD
Alfentanil—Agitation—Cimetidine—obesity	0.0006	0.00467	CcSEcCtD
Alfentanil—Dermatitis atopic—Topiramate—obesity	0.000598	0.00466	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Sibutramine—obesity	0.000598	0.00466	CcSEcCtD
Alfentanil—Somnolence—Phenylpropanolamine—obesity	0.000598	0.00465	CcSEcCtD
Alfentanil—Euphoric mood—Bupropion—obesity	0.000597	0.00465	CcSEcCtD
Alfentanil—Convulsion—Diethylpropion—obesity	0.000594	0.00463	CcSEcCtD
Alfentanil—Dizziness—Methamphetamine—obesity	0.000592	0.00461	CcSEcCtD
Alfentanil—Dizziness—Benzphetamine—obesity	0.000571	0.00445	CcSEcCtD
Alfentanil—Disorientation—Bupropion—obesity	0.000564	0.00439	CcSEcCtD
Alfentanil—Headache—Methamphetamine—obesity	0.000561	0.00437	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Phentermine—obesity	0.000555	0.00433	CcSEcCtD
Alfentanil—Fatigue—Phentermine—obesity	0.000555	0.00432	CcSEcCtD
Alfentanil—Feeling abnormal—Phenylpropanolamine—obesity	0.000554	0.00431	CcSEcCtD
Alfentanil—Cardiac arrest—Sibutramine—obesity	0.00055	0.00429	CcSEcCtD
Alfentanil—CYP3A7—liver—obesity	0.000546	0.0398	CbGeAlD
Alfentanil—Tachycardia—Diethylpropion—obesity	0.000546	0.00425	CcSEcCtD
Alfentanil—Hyperhidrosis—Diethylpropion—obesity	0.000541	0.00421	CcSEcCtD
Alfentanil—Headache—Benzphetamine—obesity	0.000541	0.00421	CcSEcCtD
Alfentanil—Confusional state—Cimetidine—obesity	0.000537	0.00418	CcSEcCtD
Alfentanil—Visual disturbance—Bupropion—obesity	0.000533	0.00415	CcSEcCtD
Alfentanil—Anaphylactic shock—Cimetidine—obesity	0.000533	0.00415	CcSEcCtD
Alfentanil—Dizziness—Phendimetrazine—obesity	0.00052	0.00405	CcSEcCtD
Alfentanil—Tachycardia—Cimetidine—obesity	0.00052	0.00405	CcSEcCtD
Alfentanil—Nausea—Benzphetamine—obesity	0.000513	0.00399	CcSEcCtD
Alfentanil—Urticaria—Phentermine—obesity	0.000511	0.00398	CcSEcCtD
Alfentanil—Bronchospasm—Orlistat—obesity	0.000509	0.00396	CcSEcCtD
Alfentanil—Somnolence—Diethylpropion—obesity	0.000498	0.00387	CcSEcCtD
Alfentanil—Hypersensitivity—Phenylpropanolamine—obesity	0.000495	0.00386	CcSEcCtD
Alfentanil—Headache—Phendimetrazine—obesity	0.000493	0.00384	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Diethylpropion—obesity	0.000483	0.00376	CcSEcCtD
Alfentanil—Somnolence—Cimetidine—obesity	0.000473	0.00369	CcSEcCtD
Alfentanil—Dyskinesia—Topiramate—obesity	0.000471	0.00367	CcSEcCtD
Alfentanil—Nausea—Phendimetrazine—obesity	0.000467	0.00364	CcSEcCtD
Alfentanil—CYP3A7-CYP3A51P—liver—obesity	0.000465	0.0338	CbGeAlD
Alfentanil—Asthenia—Phentermine—obesity	0.000462	0.00359	CcSEcCtD
Alfentanil—Feeling abnormal—Diethylpropion—obesity	0.000461	0.00359	CcSEcCtD
Alfentanil—Fatigue—Cimetidine—obesity	0.000459	0.00358	CcSEcCtD
Alfentanil—Urticaria—Diethylpropion—obesity	0.000445	0.00346	CcSEcCtD
Alfentanil—Dizziness—Phenylpropanolamine—obesity	0.000445	0.00346	CcSEcCtD
Alfentanil—Feeling abnormal—Cimetidine—obesity	0.000439	0.00342	CcSEcCtD
Alfentanil—CYP3A5—islet of Langerhans—obesity	0.00043	0.0313	CbGeAlD
Alfentanil—Bronchospasm—Bupropion—obesity	0.000429	0.00334	CcSEcCtD
Alfentanil—Vomiting—Phenylpropanolamine—obesity	0.000427	0.00333	CcSEcCtD
Alfentanil—Dizziness—Phentermine—obesity	0.000425	0.00331	CcSEcCtD
Alfentanil—Rash—Phenylpropanolamine—obesity	0.000424	0.0033	CcSEcCtD
Alfentanil—Dermatitis—Phenylpropanolamine—obesity	0.000423	0.0033	CcSEcCtD
Alfentanil—Body temperature increased—Cimetidine—obesity	0.000421	0.00328	CcSEcCtD
Alfentanil—Epistaxis—Sibutramine—obesity	0.000421	0.00328	CcSEcCtD
Alfentanil—Vomiting—Phentermine—obesity	0.000409	0.00319	CcSEcCtD
Alfentanil—Bradycardia—Sibutramine—obesity	0.000408	0.00317	CcSEcCtD
Alfentanil—CYP3A5—respiratory system—obesity	0.000406	0.0296	CbGeAlD
Alfentanil—Rash—Phentermine—obesity	0.000406	0.00316	CcSEcCtD
Alfentanil—Dermatitis—Phentermine—obesity	0.000405	0.00316	CcSEcCtD
Alfentanil—Headache—Phentermine—obesity	0.000403	0.00314	CcSEcCtD
Alfentanil—Nausea—Phenylpropanolamine—obesity	0.000399	0.00311	CcSEcCtD
Alfentanil—OPRM1—endocrine gland—obesity	0.000393	0.0286	CbGeAlD
Alfentanil—Hypersensitivity—Cimetidine—obesity	0.000392	0.00306	CcSEcCtD
Alfentanil—ALB—adrenal gland—obesity	0.000388	0.0282	CbGeAlD
Alfentanil—Visual impairment—Sibutramine—obesity	0.000386	0.00301	CcSEcCtD
Alfentanil—ORM1—endocrine gland—obesity	0.000383	0.0279	CbGeAlD
Alfentanil—Nausea—Phentermine—obesity	0.000382	0.00298	CcSEcCtD
Alfentanil—Asthenia—Cimetidine—obesity	0.000382	0.00298	CcSEcCtD
Alfentanil—Euphoric mood—Topiramate—obesity	0.000381	0.00296	CcSEcCtD
Alfentanil—Eye disorder—Sibutramine—obesity	0.000374	0.00291	CcSEcCtD
Alfentanil—Immune system disorder—Orlistat—obesity	0.000374	0.00291	CcSEcCtD
Alfentanil—Mediastinal disorder—Orlistat—obesity	0.000373	0.0029	CcSEcCtD
Alfentanil—Dizziness—Diethylpropion—obesity	0.00037	0.00288	CcSEcCtD
Alfentanil—Epistaxis—Bupropion—obesity	0.000367	0.00286	CcSEcCtD
Alfentanil—Angiopathy—Sibutramine—obesity	0.000363	0.00283	CcSEcCtD
Alfentanil—Mental disorder—Orlistat—obesity	0.000363	0.00282	CcSEcCtD
Alfentanil—Immune system disorder—Sibutramine—obesity	0.000362	0.00282	CcSEcCtD
Alfentanil—Disorientation—Topiramate—obesity	0.000359	0.0028	CcSEcCtD
Alfentanil—Chills—Sibutramine—obesity	0.000359	0.0028	CcSEcCtD
Alfentanil—Arrhythmia—Sibutramine—obesity	0.000358	0.00279	CcSEcCtD
Alfentanil—Vomiting—Diethylpropion—obesity	0.000356	0.00277	CcSEcCtD
Alfentanil—Rash—Diethylpropion—obesity	0.000353	0.00275	CcSEcCtD
Alfentanil—Dermatitis—Diethylpropion—obesity	0.000353	0.00275	CcSEcCtD
Alfentanil—Dizziness—Cimetidine—obesity	0.000352	0.00274	CcSEcCtD
Alfentanil—Headache—Diethylpropion—obesity	0.000351	0.00273	CcSEcCtD
Alfentanil—ORM1—liver—obesity	0.000346	0.0252	CbGeAlD
Alfentanil—Connective tissue disorder—Bupropion—obesity	0.000343	0.00267	CcSEcCtD
Alfentanil—Vision blurred—Orlistat—obesity	0.000339	0.00264	CcSEcCtD
Alfentanil—Visual disturbance—Topiramate—obesity	0.000339	0.00264	CcSEcCtD
Alfentanil—Vomiting—Cimetidine—obesity	0.000339	0.00264	CcSEcCtD
Alfentanil—Visual impairment—Bupropion—obesity	0.000336	0.00262	CcSEcCtD
Alfentanil—Rash—Cimetidine—obesity	0.000336	0.00261	CcSEcCtD
Alfentanil—Dermatitis—Cimetidine—obesity	0.000335	0.00261	CcSEcCtD
Alfentanil—Headache—Cimetidine—obesity	0.000334	0.0026	CcSEcCtD
Alfentanil—Nausea—Diethylpropion—obesity	0.000332	0.00259	CcSEcCtD
Alfentanil—Vision blurred—Sibutramine—obesity	0.000329	0.00256	CcSEcCtD
Alfentanil—Eye disorder—Bupropion—obesity	0.000326	0.00254	CcSEcCtD
Alfentanil—Cardiac disorder—Bupropion—obesity	0.000324	0.00252	CcSEcCtD
Alfentanil—Agitation—Sibutramine—obesity	0.00032	0.00249	CcSEcCtD
Alfentanil—Angiopathy—Bupropion—obesity	0.000317	0.00247	CcSEcCtD
Alfentanil—Nausea—Cimetidine—obesity	0.000316	0.00246	CcSEcCtD
Alfentanil—Immune system disorder—Bupropion—obesity	0.000315	0.00246	CcSEcCtD
Alfentanil—Mediastinal disorder—Bupropion—obesity	0.000315	0.00245	CcSEcCtD
Alfentanil—Cough—Orlistat—obesity	0.000314	0.00245	CcSEcCtD
Alfentanil—Chills—Bupropion—obesity	0.000313	0.00244	CcSEcCtD
Alfentanil—Convulsion—Orlistat—obesity	0.000312	0.00243	CcSEcCtD
Alfentanil—Arrhythmia—Bupropion—obesity	0.000312	0.00243	CcSEcCtD
Alfentanil—Loss of consciousness—Sibutramine—obesity	0.000306	0.00239	CcSEcCtD
Alfentanil—Mental disorder—Bupropion—obesity	0.000306	0.00238	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000305	0.00237	CcSEcCtD
Alfentanil—Cough—Sibutramine—obesity	0.000304	0.00237	CcSEcCtD
Alfentanil—ALB—liver—obesity	0.000303	0.0221	CbGeAlD
Alfentanil—Convulsion—Sibutramine—obesity	0.000302	0.00235	CcSEcCtD
Alfentanil—Hypertension—Sibutramine—obesity	0.000301	0.00234	CcSEcCtD
Alfentanil—Anaphylactic shock—Orlistat—obesity	0.000294	0.00229	CcSEcCtD
Alfentanil—Nervous system disorder—Orlistat—obesity	0.000288	0.00225	CcSEcCtD
Alfentanil—Confusional state—Sibutramine—obesity	0.000287	0.00223	CcSEcCtD
Alfentanil—Vision blurred—Bupropion—obesity	0.000286	0.00223	CcSEcCtD
Alfentanil—Skin disorder—Orlistat—obesity	0.000286	0.00222	CcSEcCtD
Alfentanil—Anaphylactic shock—Sibutramine—obesity	0.000285	0.00222	CcSEcCtD
Alfentanil—Hyperhidrosis—Orlistat—obesity	0.000284	0.00221	CcSEcCtD
Alfentanil—Agitation—Bupropion—obesity	0.000279	0.00217	CcSEcCtD
Alfentanil—Tachycardia—Sibutramine—obesity	0.000278	0.00216	CcSEcCtD
Alfentanil—Skin disorder—Sibutramine—obesity	0.000276	0.00215	CcSEcCtD
Alfentanil—Hyperhidrosis—Sibutramine—obesity	0.000275	0.00214	CcSEcCtD
Alfentanil—CYP3A5—adipose tissue—obesity	0.000274	0.02	CbGeAlD
Alfentanil—Loss of consciousness—Bupropion—obesity	0.000267	0.00208	CcSEcCtD
Alfentanil—Hypotension—Sibutramine—obesity	0.000266	0.00207	CcSEcCtD
Alfentanil—Cough—Bupropion—obesity	0.000265	0.00207	CcSEcCtD
Alfentanil—Convulsion—Bupropion—obesity	0.000263	0.00205	CcSEcCtD
Alfentanil—Hypertension—Bupropion—obesity	0.000262	0.00204	CcSEcCtD
Alfentanil—CYP3A5—digestive system—obesity	0.000258	0.0188	CbGeAlD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000257	0.002	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Orlistat—obesity	0.000254	0.00198	CcSEcCtD
Alfentanil—Fatigue—Orlistat—obesity	0.000253	0.00197	CcSEcCtD
Alfentanil—Somnolence—Sibutramine—obesity	0.000253	0.00197	CcSEcCtD
Alfentanil—Pain—Orlistat—obesity	0.000251	0.00196	CcSEcCtD
Alfentanil—Confusional state—Bupropion—obesity	0.00025	0.00195	CcSEcCtD
Alfentanil—Anaphylactic shock—Bupropion—obesity	0.000248	0.00193	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Sibutramine—obesity	0.000246	0.00191	CcSEcCtD
Alfentanil—Pain—Sibutramine—obesity	0.000243	0.00189	CcSEcCtD
Alfentanil—Nervous system disorder—Bupropion—obesity	0.000243	0.00189	CcSEcCtD
Alfentanil—Feeling abnormal—Orlistat—obesity	0.000242	0.00189	CcSEcCtD
Alfentanil—Tachycardia—Bupropion—obesity	0.000242	0.00189	CcSEcCtD
Alfentanil—Skin disorder—Bupropion—obesity	0.000241	0.00188	CcSEcCtD
Alfentanil—Hyperhidrosis—Bupropion—obesity	0.00024	0.00187	CcSEcCtD
Alfentanil—Feeling abnormal—Sibutramine—obesity	0.000234	0.00183	CcSEcCtD
Alfentanil—Epistaxis—Topiramate—obesity	0.000234	0.00182	CcSEcCtD
Alfentanil—Urticaria—Orlistat—obesity	0.000234	0.00182	CcSEcCtD
Alfentanil—Body temperature increased—Orlistat—obesity	0.000232	0.00181	CcSEcCtD
Alfentanil—Hypotension—Bupropion—obesity	0.000232	0.0018	CcSEcCtD
Alfentanil—ABCB1—islet of Langerhans—obesity	0.000228	0.0166	CbGeAlD
Alfentanil—Bradycardia—Topiramate—obesity	0.000226	0.00176	CcSEcCtD
Alfentanil—Urticaria—Sibutramine—obesity	0.000226	0.00176	CcSEcCtD
Alfentanil—Body temperature increased—Sibutramine—obesity	0.000225	0.00175	CcSEcCtD
Alfentanil—Somnolence—Bupropion—obesity	0.000221	0.00172	CcSEcCtD
Alfentanil—Connective tissue disorder—Topiramate—obesity	0.000219	0.0017	CcSEcCtD
Alfentanil—Hypersensitivity—Orlistat—obesity	0.000217	0.00169	CcSEcCtD
Alfentanil—ABCB1—respiratory system—obesity	0.000216	0.0157	CbGeAlD
Alfentanil—Visual impairment—Topiramate—obesity	0.000214	0.00167	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Bupropion—obesity	0.000214	0.00167	CcSEcCtD
Alfentanil—Fatigue—Bupropion—obesity	0.000214	0.00167	CcSEcCtD
Alfentanil—CYP3A5—endocrine gland—obesity	0.000213	0.0155	CbGeAlD
Alfentanil—Pain—Bupropion—obesity	0.000212	0.00165	CcSEcCtD
Alfentanil—Asthenia—Orlistat—obesity	0.000211	0.00164	CcSEcCtD
Alfentanil—Hypersensitivity—Sibutramine—obesity	0.00021	0.00163	CcSEcCtD
Alfentanil—Pruritus—Orlistat—obesity	0.000208	0.00162	CcSEcCtD
Alfentanil—Eye disorder—Topiramate—obesity	0.000208	0.00162	CcSEcCtD
Alfentanil—Cardiac disorder—Topiramate—obesity	0.000206	0.00161	CcSEcCtD
Alfentanil—Feeling abnormal—Bupropion—obesity	0.000204	0.00159	CcSEcCtD
Alfentanil—Asthenia—Sibutramine—obesity	0.000204	0.00159	CcSEcCtD
Alfentanil—Angiopathy—Topiramate—obesity	0.000202	0.00157	CcSEcCtD
Alfentanil—Pruritus—Sibutramine—obesity	0.000201	0.00157	CcSEcCtD
Alfentanil—Immune system disorder—Topiramate—obesity	0.000201	0.00156	CcSEcCtD
Alfentanil—Mediastinal disorder—Topiramate—obesity	0.0002	0.00156	CcSEcCtD
Alfentanil—Chills—Topiramate—obesity	0.0002	0.00155	CcSEcCtD
Alfentanil—Urticaria—Bupropion—obesity	0.000197	0.00153	CcSEcCtD
Alfentanil—Body temperature increased—Bupropion—obesity	0.000196	0.00153	CcSEcCtD
Alfentanil—Mental disorder—Topiramate—obesity	0.000195	0.00152	CcSEcCtD
Alfentanil—Dizziness—Orlistat—obesity	0.000194	0.00151	CcSEcCtD
Alfentanil—CYP3A4—digestive system—obesity	0.000194	0.0141	CbGeAlD
Alfentanil—Erythema—Topiramate—obesity	0.000194	0.00151	CcSEcCtD
Alfentanil—CYP3A5—liver—obesity	0.000192	0.014	CbGeAlD
Alfentanil—Dizziness—Sibutramine—obesity	0.000188	0.00147	CcSEcCtD
Alfentanil—Vomiting—Orlistat—obesity	0.000187	0.00146	CcSEcCtD
Alfentanil—Rash—Orlistat—obesity	0.000185	0.00144	CcSEcCtD
Alfentanil—Dermatitis—Orlistat—obesity	0.000185	0.00144	CcSEcCtD
Alfentanil—Headache—Orlistat—obesity	0.000184	0.00143	CcSEcCtD
Alfentanil—Hypersensitivity—Bupropion—obesity	0.000183	0.00142	CcSEcCtD
Alfentanil—Vision blurred—Topiramate—obesity	0.000182	0.00142	CcSEcCtD
Alfentanil—ABCB1—adrenal cortex—obesity	0.000181	0.0132	CbGeAlD
Alfentanil—Vomiting—Sibutramine—obesity	0.000181	0.00141	CcSEcCtD
Alfentanil—Rash—Sibutramine—obesity	0.000179	0.0014	CcSEcCtD
Alfentanil—Dermatitis—Sibutramine—obesity	0.000179	0.0014	CcSEcCtD
Alfentanil—Headache—Sibutramine—obesity	0.000178	0.00139	CcSEcCtD
Alfentanil—Asthenia—Bupropion—obesity	0.000178	0.00139	CcSEcCtD
Alfentanil—Agitation—Topiramate—obesity	0.000178	0.00139	CcSEcCtD
Alfentanil—Pruritus—Bupropion—obesity	0.000175	0.00137	CcSEcCtD
Alfentanil—Nausea—Orlistat—obesity	0.000175	0.00136	CcSEcCtD
Alfentanil—Loss of consciousness—Topiramate—obesity	0.00017	0.00133	CcSEcCtD
Alfentanil—Nausea—Sibutramine—obesity	0.000169	0.00132	CcSEcCtD
Alfentanil—Cough—Topiramate—obesity	0.000169	0.00132	CcSEcCtD
Alfentanil—Convulsion—Topiramate—obesity	0.000168	0.00131	CcSEcCtD
Alfentanil—Hypertension—Topiramate—obesity	0.000167	0.0013	CcSEcCtD
Alfentanil—ABCB1—cardiovascular system—obesity	0.000165	0.012	CbGeAlD
Alfentanil—Dizziness—Bupropion—obesity	0.000164	0.00128	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000164	0.00127	CcSEcCtD
Alfentanil—CYP3A4—endocrine gland—obesity	0.00016	0.0117	CbGeAlD
Alfentanil—Confusional state—Topiramate—obesity	0.000159	0.00124	CcSEcCtD
Alfentanil—Vomiting—Bupropion—obesity	0.000158	0.00123	CcSEcCtD
Alfentanil—Rash—Bupropion—obesity	0.000156	0.00122	CcSEcCtD
Alfentanil—Dermatitis—Bupropion—obesity	0.000156	0.00122	CcSEcCtD
Alfentanil—Headache—Bupropion—obesity	0.000155	0.00121	CcSEcCtD
Alfentanil—Nervous system disorder—Topiramate—obesity	0.000155	0.00121	CcSEcCtD
Alfentanil—Tachycardia—Topiramate—obesity	0.000154	0.0012	CcSEcCtD
Alfentanil—Skin disorder—Topiramate—obesity	0.000153	0.0012	CcSEcCtD
Alfentanil—Hyperhidrosis—Topiramate—obesity	0.000153	0.00119	CcSEcCtD
Alfentanil—Hypotension—Topiramate—obesity	0.000148	0.00115	CcSEcCtD
Alfentanil—Nausea—Bupropion—obesity	0.000147	0.00115	CcSEcCtD
Alfentanil—ABCB1—pituitary gland—obesity	0.000146	0.0107	CbGeAlD
Alfentanil—ABCB1—adipose tissue—obesity	0.000146	0.0106	CbGeAlD
Alfentanil—CYP3A4—liver—obesity	0.000144	0.0105	CbGeAlD
Alfentanil—Somnolence—Topiramate—obesity	0.00014	0.00109	CcSEcCtD
Alfentanil—ABCB1—digestive system—obesity	0.000137	0.00999	CbGeAlD
Alfentanil—Gastrointestinal disorder—Topiramate—obesity	0.000136	0.00106	CcSEcCtD
Alfentanil—Fatigue—Topiramate—obesity	0.000136	0.00106	CcSEcCtD
Alfentanil—Pain—Topiramate—obesity	0.000135	0.00105	CcSEcCtD
Alfentanil—ABCB1—adrenal gland—obesity	0.000131	0.00952	CbGeAlD
Alfentanil—Feeling abnormal—Topiramate—obesity	0.00013	0.00101	CcSEcCtD
Alfentanil—Urticaria—Topiramate—obesity	0.000126	0.000978	CcSEcCtD
Alfentanil—Body temperature increased—Topiramate—obesity	0.000125	0.000973	CcSEcCtD
Alfentanil—Hypersensitivity—Topiramate—obesity	0.000116	0.000907	CcSEcCtD
Alfentanil—Asthenia—Topiramate—obesity	0.000113	0.000883	CcSEcCtD
Alfentanil—ABCB1—endocrine gland—obesity	0.000113	0.00825	CbGeAlD
Alfentanil—Pruritus—Topiramate—obesity	0.000112	0.000871	CcSEcCtD
Alfentanil—Dizziness—Topiramate—obesity	0.000105	0.000814	CcSEcCtD
Alfentanil—ABCB1—liver—obesity	0.000102	0.00744	CbGeAlD
Alfentanil—Vomiting—Topiramate—obesity	0.0001	0.000782	CcSEcCtD
Alfentanil—Rash—Topiramate—obesity	9.96e-05	0.000776	CcSEcCtD
Alfentanil—Dermatitis—Topiramate—obesity	9.95e-05	0.000775	CcSEcCtD
Alfentanil—Headache—Topiramate—obesity	9.9e-05	0.000771	CcSEcCtD
Alfentanil—Nausea—Topiramate—obesity	9.39e-05	0.000731	CcSEcCtD
Alfentanil—CYP3A5—Metabolism—CYP19A1—obesity	6.81e-06	9.11e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—STK11—obesity	6.81e-06	9.11e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CETP—obesity	6.78e-06	9.07e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FABP4—obesity	6.76e-06	9.04e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GLUL—obesity	6.76e-06	9.04e-05	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—obesity	6.76e-06	9.04e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AGT—obesity	6.73e-06	9e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SDC1—obesity	6.7e-06	8.97e-05	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	6.66e-06	8.9e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKR1C3—obesity	6.59e-06	8.82e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOE—obesity	6.59e-06	8.82e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2E1—obesity	6.58e-06	8.8e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IRS2—obesity	6.55e-06	8.76e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AGT—obesity	6.54e-06	8.75e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CAV1—obesity	6.53e-06	8.73e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOA1—obesity	6.51e-06	8.71e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NQO1—obesity	6.51e-06	8.7e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SCARB1—obesity	6.49e-06	8.69e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UCP3—obesity	6.41e-06	8.57e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HSD11B1—obesity	6.41e-06	8.57e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ECHS1—obesity	6.41e-06	8.57e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UCP2—obesity	6.41e-06	8.57e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOE—obesity	6.41e-06	8.57e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—LEP—obesity	6.41e-06	8.57e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	6.37e-06	8.52e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CAV1—obesity	6.35e-06	8.49e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOA1—obesity	6.33e-06	8.47e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—COMT—obesity	6.33e-06	8.47e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	6.31e-06	8.44e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADH1B—obesity	6.31e-06	8.44e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SREBF1—obesity	6.3e-06	8.43e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GNB3—obesity	6.24e-06	8.35e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARGC1A—obesity	6.24e-06	8.35e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GCG—obesity	6.24e-06	8.34e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC2A4—obesity	6.24e-06	8.34e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—obesity	6.21e-06	8.31e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ACSL1—obesity	6.21e-06	8.3e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GPAM—obesity	6.21e-06	8.3e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARGC1B—obesity	6.21e-06	8.3e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYCS—obesity	6.16e-06	8.23e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GOT2—obesity	6.13e-06	8.2e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ESR1—obesity	6.12e-06	8.18e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GNAS—obesity	6.08e-06	8.13e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCB—obesity	6.04e-06	8.08e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—F2—obesity	6.04e-06	8.08e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GOT1—obesity	6.04e-06	8.08e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GGT1—obesity	6.04e-06	8.08e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PCK1—obesity	6.03e-06	8.06e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HADH—obesity	6.03e-06	8.06e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FADS1—obesity	6.03e-06	8.06e-05	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—obesity	6.01e-06	8.04e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—FASN—obesity	6e-06	8.03e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BCHE—obesity	5.97e-06	7.99e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BAD—obesity	5.97e-06	7.99e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOB—obesity	5.95e-06	7.96e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NCOA1—obesity	5.95e-06	7.96e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CG—obesity	5.95e-06	7.96e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—STK11—obesity	5.86e-06	7.84e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP19A1—obesity	5.86e-06	7.84e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ACP5—obesity	5.86e-06	7.84e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CG—obesity	5.78e-06	7.73e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2E1—obesity	5.76e-06	7.71e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARG—obesity	5.74e-06	7.68e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IRS1—obesity	5.72e-06	7.65e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—G6PD—obesity	5.71e-06	7.64e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NQO1—obesity	5.7e-06	7.63e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—LPL—obesity	5.68e-06	7.6e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—POMC—obesity	5.66e-06	7.57e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SREBF2—obesity	5.64e-06	7.55e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HK1—obesity	5.64e-06	7.55e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—INS—obesity	5.63e-06	7.53e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GPX1—obesity	5.54e-06	7.42e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—POMC—obesity	5.5e-06	7.36e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—INS—obesity	5.47e-06	7.32e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC2A4—obesity	5.46e-06	7.31e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GCG—obesity	5.46e-06	7.31e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—COMT—obesity	5.45e-06	7.29e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LPA—obesity	5.45e-06	7.29e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CD36—obesity	5.4e-06	7.22e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYCS—obesity	5.39e-06	7.22e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL2—obesity	5.38e-06	7.2e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GNB3—obesity	5.38e-06	7.19e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARGC1A—obesity	5.38e-06	7.19e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—obesity	5.35e-06	7.16e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LPIN1—obesity	5.33e-06	7.13e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1—obesity	5.29e-06	7.08e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GOT1—obesity	5.29e-06	7.08e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GGT1—obesity	5.29e-06	7.08e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT2—obesity	5.29e-06	7.08e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GNAS—obesity	5.23e-06	7e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CD—obesity	5.23e-06	6.99e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA5—obesity	5.22e-06	6.99e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NCOA1—obesity	5.21e-06	6.97e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—obesity	5.16e-06	6.9e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—STK11—obesity	5.14e-06	6.87e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP19A1—obesity	5.14e-06	6.87e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOB—obesity	5.13e-06	6.86e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MTHFR—obesity	5.12e-06	6.84e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CD—obesity	5.08e-06	6.8e-05	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—obesity	5.03e-06	6.74e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SERPINE1—obesity	5.03e-06	6.73e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARA—obesity	5.02e-06	6.72e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TGFB1—obesity	5.01e-06	6.71e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC22A1—obesity	4.98e-06	6.67e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CLOCK—obesity	4.98e-06	6.67e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3R1—obesity	4.94e-06	6.6e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NOS3—obesity	4.94e-06	6.6e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—LPL—obesity	4.89e-06	6.55e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TYK2—obesity	4.89e-06	6.54e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AGT—obesity	4.86e-06	6.5e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SULT2A1—obesity	4.86e-06	6.5e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GLP1R—obesity	4.86e-06	6.5e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RHOA—obesity	4.85e-06	6.49e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOS3—obesity	4.8e-06	6.42e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3R1—obesity	4.8e-06	6.42e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—DPYD—obesity	4.78e-06	6.39e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—COMT—obesity	4.78e-06	6.39e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GPX1—obesity	4.77e-06	6.39e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOE—obesity	4.76e-06	6.37e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAV1—obesity	4.72e-06	6.31e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GNB3—obesity	4.71e-06	6.3e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARGC1A—obesity	4.71e-06	6.3e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOA1—obesity	4.71e-06	6.3e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—obesity	4.69e-06	6.27e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CD36—obesity	4.65e-06	6.22e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PRKAR2B—obesity	4.6e-06	6.15e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GNAS—obesity	4.59e-06	6.13e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—obesity	4.57e-06	6.12e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—DCN—obesity	4.57e-06	6.11e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CB—obesity	4.56e-06	6.1e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—obesity	4.52e-06	6.04e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOB—obesity	4.49e-06	6.01e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CPT1A—obesity	4.44e-06	5.94e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CB—obesity	4.43e-06	5.93e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MTOR—obesity	4.43e-06	5.93e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTHFR—obesity	4.41e-06	5.89e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NAMPT—obesity	4.36e-06	5.83e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LIPC—obesity	4.33e-06	5.79e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GCK—obesity	4.33e-06	5.79e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARA—obesity	4.32e-06	5.78e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOC3—obesity	4.3e-06	5.76e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CG—obesity	4.3e-06	5.75e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—LPL—obesity	4.29e-06	5.74e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—obesity	4.27e-06	5.71e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AGT—obesity	4.19e-06	5.6e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GPX1—obesity	4.18e-06	5.6e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CETP—obesity	4.18e-06	5.59e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARG—obesity	4.15e-06	5.55e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SDC1—obesity	4.13e-06	5.53e-05	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—obesity	4.11e-06	5.5e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOE—obesity	4.1e-06	5.49e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—POMC—obesity	4.09e-06	5.47e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CD36—obesity	4.07e-06	5.45e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—INS—obesity	4.07e-06	5.44e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAV1—obesity	4.06e-06	5.44e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKR1C3—obesity	4.06e-06	5.44e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOA1—obesity	4.06e-06	5.43e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—obesity	4.05e-06	5.42e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SCARB1—obesity	4e-06	5.35e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.88e-06	5.19e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SREBF1—obesity	3.88e-06	5.19e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTHFR—obesity	3.86e-06	5.17e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—obesity	3.85e-06	5.15e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARA—obesity	3.79e-06	5.07e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CD—obesity	3.78e-06	5.06e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GOT2—obesity	3.78e-06	5.05e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK8—obesity	3.74e-06	5.01e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—obesity	3.73e-06	5e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—obesity	3.73e-06	4.99e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CG—obesity	3.7e-06	4.95e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FASN—obesity	3.7e-06	4.95e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BCHE—obesity	3.68e-06	4.92e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AGT—obesity	3.67e-06	4.91e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOE—obesity	3.59e-06	4.81e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARG—obesity	3.57e-06	4.78e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NOS3—obesity	3.57e-06	4.77e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3R1—obesity	3.57e-06	4.77e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAV1—obesity	3.56e-06	4.76e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOA1—obesity	3.55e-06	4.75e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2E1—obesity	3.55e-06	4.75e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—POMC—obesity	3.52e-06	4.71e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NQO1—obesity	3.51e-06	4.7e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—INS—obesity	3.5e-06	4.69e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—obesity	3.48e-06	4.66e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT3—obesity	3.42e-06	4.58e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GCG—obesity	3.37e-06	4.5e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC2A4—obesity	3.37e-06	4.5e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYCS—obesity	3.32e-06	4.45e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CB—obesity	3.29e-06	4.41e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—obesity	3.26e-06	4.37e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GGT1—obesity	3.26e-06	4.36e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GOT1—obesity	3.26e-06	4.36e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CD—obesity	3.25e-06	4.35e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CG—obesity	3.24e-06	4.34e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NCOA1—obesity	3.21e-06	4.3e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—obesity	3.18e-06	4.26e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TGFB1—obesity	3.17e-06	4.25e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—STK11—obesity	3.17e-06	4.23e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP19A1—obesity	3.17e-06	4.23e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARG—obesity	3.13e-06	4.19e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—POMC—obesity	3.09e-06	4.13e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3R1—obesity	3.07e-06	4.11e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NOS3—obesity	3.07e-06	4.11e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—INS—obesity	3.07e-06	4.11e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—COMT—obesity	2.94e-06	3.94e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GNB3—obesity	2.9e-06	3.88e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARGC1A—obesity	2.9e-06	3.88e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—obesity	2.89e-06	3.86e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CD—obesity	2.85e-06	3.81e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CB—obesity	2.84e-06	3.8e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GNAS—obesity	2.83e-06	3.78e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—obesity	2.82e-06	3.77e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—obesity	2.81e-06	3.76e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—obesity	2.78e-06	3.72e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOB—obesity	2.77e-06	3.7e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—obesity	2.7e-06	3.61e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3R1—obesity	2.69e-06	3.6e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NOS3—obesity	2.69e-06	3.6e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LPL—obesity	2.64e-06	3.53e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GPX1—obesity	2.58e-06	3.45e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CD36—obesity	2.51e-06	3.36e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CB—obesity	2.49e-06	3.33e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—obesity	2.46e-06	3.29e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—obesity	2.39e-06	3.2e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTHFR—obesity	2.38e-06	3.18e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARA—obesity	2.33e-06	3.12e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—obesity	2.27e-06	3.04e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AGT—obesity	2.26e-06	3.02e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOE—obesity	2.21e-06	2.96e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—obesity	2.21e-06	2.95e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAV1—obesity	2.19e-06	2.94e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA1—obesity	2.19e-06	2.93e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—obesity	2.01e-06	2.69e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CG—obesity	2e-06	2.67e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARG—obesity	1.93e-06	2.58e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—POMC—obesity	1.9e-06	2.54e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—INS—obesity	1.89e-06	2.53e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CD—obesity	1.76e-06	2.35e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—obesity	1.73e-06	2.32e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—obesity	1.73e-06	2.31e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3R1—obesity	1.66e-06	2.22e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NOS3—obesity	1.66e-06	2.22e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—obesity	1.64e-06	2.19e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CB—obesity	1.53e-06	2.05e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—obesity	1.52e-06	2.03e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—obesity	1.52e-06	2.03e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—obesity	1.41e-06	1.89e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—obesity	1.24e-06	1.66e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—obesity	9.34e-07	1.25e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—obesity	7.63e-07	1.02e-05	CbGpPWpGaD
